Basal insulin is long-acting insulin taken once or twice daily to keep blood sugar stable between meals and overnight. Common options include Lantus (glargine), Tresiba (degludec), Toujeo (concentrated glargine), and Levemir (detemir). It is the foundation of insulin therapy for both Type 1 and Type 2 diabetes.
Basal insulin provides continuous background insulin coverage — the steady baseline your body needs to prevent blood sugar from rising between meals and overnight. It works differently from mealtime insulin and is the cornerstone of insulin therapy for most people with Type 1 diabetes and many with Type 2.
How Basal Insulin Works
In a person without diabetes, the pancreas continuously secretes small amounts of insulin throughout the day and night to suppress the liver from releasing glucose. Without this basal coverage, the liver overproduces glucose — causing elevated fasting blood sugar. Basal insulin replaces this continuous background secretion.
🔑 Basal vs. Mealtime: Basal insulin controls your fasting blood sugar (morning glucose before eating). Mealtime (bolus) insulin controls the rise after meals. If your fasting glucose is consistently high, basal insulin adjustment is needed — not more mealtime insulin.
The Main Basal Insulins
| Insulin | Brand(s) | Duration | Peak | Dosing |
|---|---|---|---|---|
| Glargine U-100 | Lantus, Basaglar, Semglee | ~24 hrs | Peakless | Once daily |
| Glargine U-300 | Toujeo | >24 hrs | Peakless | Once daily |
| Detemir | Levemir | 18–22 hrs | Minimal | Once or twice daily |
| Degludec | Tresiba | ~42 hrs | Peakless | Once daily (flexible timing) |
Tresiba (degludec) has the longest and flattest action profile — it reaches steady state after 3–4 days and has the lowest hypoglycemia risk of any basal insulin. It is also timing-flexible (can be taken at different times as long as 8 hours apart). Toujeo is more concentrated and may provide more consistent coverage than Lantus U-100 in some patients.
How to Inject Basal Insulin
- Inject subcutaneously (under the skin) — abdomen, thigh, or upper arm
- Rotate injection sites within the same area to prevent lipohypertrophy (fatty lumps that impair absorption)
- Never inject into areas with lipohypertrophy — absorption is unpredictable
- Store open pens at room temperature (up to 28–30 days); unopened pens in refrigerator
- Glargine U-100 and U-300 are clear solutions — do not mix with other insulins in the same syringe
Titration: How to Adjust Your Dose
The most commonly used fasting-based titration method:
- Check fasting glucose (before breakfast) for 3 consecutive days
- If the average is above your target (typically 80–130 mg/dL), increase basal dose by 2 units
- Wait 3 days before increasing again
- If you experience hypoglycemia (below 70 mg/dL), do not increase — reduce by 2–4 units and contact your provider
This "2-2-2" or "treat-to-target" approach is widely validated and can be done at home in coordination with your endocrinologist.
The Dawn Phenomenon
Many people with diabetes notice elevated fasting glucose despite adequate basal insulin — this is the dawn phenomenon. Between 4–8 am, hormones (growth hormone, cortisol) naturally rise and stimulate glucose release from the liver. A longer-acting basal insulin (Tresiba, Toujeo) or shifting injection to bedtime may help.
Cost & Biosimilars
Brand-name basal insulins can be expensive. Biosimilar glargine (Basaglar, Semglee, Rezvoglar) are FDA-approved interchangeable options at lower cost. Many manufacturers offer patient assistance programs. Ask our office or your pharmacist about the most affordable option for your situation.
Key Takeaways
- Basal insulin provides continuous background coverage — it controls fasting blood sugar, not meals
- Main options: Lantus/Basaglar (glargine U-100), Toujeo (glargine U-300), Levemir (detemir), Tresiba (degludec)
- Tresiba has the longest action, flattest profile, lowest hypoglycemia risk, and flexible timing
- Titrate by fasting glucose: increase 2 units every 3 days if fasting is above target
- Never increase if you had hypoglycemia — reduce and call your provider
- Biosimilar glargines (Basaglar, Semglee) are interchangeable and often cheaper
- Rotate injection sites to prevent lipohypertrophy
Our Team Can Help
All five of our providers diagnose and manage endocrine conditions. Book with any member of our team:
Book an Appointment → or call 832-968-7003